Masseter muscle fibre changes following reduction of masticatory function

C. Y. Tsai, Y. C. Lin, B. Su, L. Y. Yang, W. C. Chiu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

This study evaluated histological changes in masseter muscle fibres following reduced masticatory function by injection of botulinum toxin type A (BTX). Sixty 30-day-old Long-Evans male rats were randomly separated into four groups (15 per group): group I BTX masseter, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral masseter muscle whilst bilateral temporalis muscles received an equal amount of normal saline; group II BTX temporalis, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral temporalis muscle whilst bilateral masseter muscle received an equal amount of normal saline; group III BTX temporalis and masseter, bilateral temporalis and masseter were given 25 U/ml (0.04 ml each muscle) BTX; group IV normal saline (control), bilateral temporalis and masseter were given normal saline (0.04 ml each muscle). After 45 days, the rats were killed, the muscles dissected and mean muscle mass recorded. The superficial masseter muscles were immunohistochemically analysed. Fibre sizes in group III were bigger than those in other groups. There was a small percentage of type IIa fibres in group III. Reduction in muscle fibre size and transition of muscle fibre subtypes from type IIa to IIx or IIb fibres may occur due to reduced masticatory function.

Original languageEnglish
Pages (from-to)394-399
Number of pages6
JournalInternational Journal of Oral and Maxillofacial Surgery
Volume41
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Masseter Muscle
Muscles
Long Evans Rats
Type A Botulinum Toxins

Keywords

  • botulinum neurotoxin
  • masseter muscle
  • muscle fibre
  • muscle tissue
  • reduced masticatory function

ASJC Scopus subject areas

  • Oral Surgery
  • Otorhinolaryngology
  • Surgery

Cite this

Masseter muscle fibre changes following reduction of masticatory function. / Tsai, C. Y.; Lin, Y. C.; Su, B.; Yang, L. Y.; Chiu, W. C.

In: International Journal of Oral and Maxillofacial Surgery, Vol. 41, No. 3, 03.2012, p. 394-399.

Research output: Contribution to journalArticle

Tsai, C. Y. ; Lin, Y. C. ; Su, B. ; Yang, L. Y. ; Chiu, W. C. / Masseter muscle fibre changes following reduction of masticatory function. In: International Journal of Oral and Maxillofacial Surgery. 2012 ; Vol. 41, No. 3. pp. 394-399.
@article{76d9d43658b24cb0a82334c8bc3cdc3d,
title = "Masseter muscle fibre changes following reduction of masticatory function",
abstract = "This study evaluated histological changes in masseter muscle fibres following reduced masticatory function by injection of botulinum toxin type A (BTX). Sixty 30-day-old Long-Evans male rats were randomly separated into four groups (15 per group): group I BTX masseter, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral masseter muscle whilst bilateral temporalis muscles received an equal amount of normal saline; group II BTX temporalis, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral temporalis muscle whilst bilateral masseter muscle received an equal amount of normal saline; group III BTX temporalis and masseter, bilateral temporalis and masseter were given 25 U/ml (0.04 ml each muscle) BTX; group IV normal saline (control), bilateral temporalis and masseter were given normal saline (0.04 ml each muscle). After 45 days, the rats were killed, the muscles dissected and mean muscle mass recorded. The superficial masseter muscles were immunohistochemically analysed. Fibre sizes in group III were bigger than those in other groups. There was a small percentage of type IIa fibres in group III. Reduction in muscle fibre size and transition of muscle fibre subtypes from type IIa to IIx or IIb fibres may occur due to reduced masticatory function.",
keywords = "botulinum neurotoxin, masseter muscle, muscle fibre, muscle tissue, reduced masticatory function",
author = "Tsai, {C. Y.} and Lin, {Y. C.} and B. Su and Yang, {L. Y.} and Chiu, {W. C.}",
year = "2012",
month = "3",
doi = "10.1016/j.ijom.2011.10.016",
language = "English",
volume = "41",
pages = "394--399",
journal = "International Journal of Oral and Maxillofacial Surgery",
issn = "0901-5027",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Masseter muscle fibre changes following reduction of masticatory function

AU - Tsai, C. Y.

AU - Lin, Y. C.

AU - Su, B.

AU - Yang, L. Y.

AU - Chiu, W. C.

PY - 2012/3

Y1 - 2012/3

N2 - This study evaluated histological changes in masseter muscle fibres following reduced masticatory function by injection of botulinum toxin type A (BTX). Sixty 30-day-old Long-Evans male rats were randomly separated into four groups (15 per group): group I BTX masseter, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral masseter muscle whilst bilateral temporalis muscles received an equal amount of normal saline; group II BTX temporalis, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral temporalis muscle whilst bilateral masseter muscle received an equal amount of normal saline; group III BTX temporalis and masseter, bilateral temporalis and masseter were given 25 U/ml (0.04 ml each muscle) BTX; group IV normal saline (control), bilateral temporalis and masseter were given normal saline (0.04 ml each muscle). After 45 days, the rats were killed, the muscles dissected and mean muscle mass recorded. The superficial masseter muscles were immunohistochemically analysed. Fibre sizes in group III were bigger than those in other groups. There was a small percentage of type IIa fibres in group III. Reduction in muscle fibre size and transition of muscle fibre subtypes from type IIa to IIx or IIb fibres may occur due to reduced masticatory function.

AB - This study evaluated histological changes in masseter muscle fibres following reduced masticatory function by injection of botulinum toxin type A (BTX). Sixty 30-day-old Long-Evans male rats were randomly separated into four groups (15 per group): group I BTX masseter, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral masseter muscle whilst bilateral temporalis muscles received an equal amount of normal saline; group II BTX temporalis, 25 U/ml (0.04 ml each muscle) BTX was injected in bilateral temporalis muscle whilst bilateral masseter muscle received an equal amount of normal saline; group III BTX temporalis and masseter, bilateral temporalis and masseter were given 25 U/ml (0.04 ml each muscle) BTX; group IV normal saline (control), bilateral temporalis and masseter were given normal saline (0.04 ml each muscle). After 45 days, the rats were killed, the muscles dissected and mean muscle mass recorded. The superficial masseter muscles were immunohistochemically analysed. Fibre sizes in group III were bigger than those in other groups. There was a small percentage of type IIa fibres in group III. Reduction in muscle fibre size and transition of muscle fibre subtypes from type IIa to IIx or IIb fibres may occur due to reduced masticatory function.

KW - botulinum neurotoxin

KW - masseter muscle

KW - muscle fibre

KW - muscle tissue

KW - reduced masticatory function

UR - http://www.scopus.com/inward/record.url?scp=84858159891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858159891&partnerID=8YFLogxK

U2 - 10.1016/j.ijom.2011.10.016

DO - 10.1016/j.ijom.2011.10.016

M3 - Article

VL - 41

SP - 394

EP - 399

JO - International Journal of Oral and Maxillofacial Surgery

JF - International Journal of Oral and Maxillofacial Surgery

SN - 0901-5027

IS - 3

ER -